Winnergy Medical Public Company Limited

WINMED · BK · Healthcare / Medical Distribution

1.23THB-0.01 (-0.81%)

Price History

Full chart

Market Stats

Previous Close1.24

Open1.23

Day Range1.22 – 1.24

52-Week Range0.6803 – 1.51

Volume72.60K

Market Cap512.00M

P/E (TTM)32.00

Forward P/E0.00

EPS0.04

Dividend Yield1.00%

Beta0.23

50-Day Avg1.13

200-Day Avg0.9505

About

Winnergy Medical Public Company Limited engages in the distribution of medical and diagnostic equipment in Thailand. The company imports and distributes technology and diagnostic kits for cervical cancer screening, including cytology examinations using automatic slide preparation machines and testing for human papilloma virus, and colposcopes. It also offers equipment for testing blood quality and blood collection bags for blood donation; blood quality testing products; blood freezers; blood banking, including pathogen inactivation; blood bag tube sealer; blood donor chairs; instrument for counting the number of leukocytes residual in blood; and device used to cut and connect both dry and wet blood bags. In addition, the company sells mosquito trappers for outdoor and indoor use; and offers HPV and STI self-collect test kits under AVA name. The company was formerly known as Winnergy Medical Co., Ltd. and changed its name to Winnergy Medical Public Company Limited in September 2020. Winnergy Medical Public Company Limited was incorporated in 2004 and is headquartered in Bangkok, Thailand.

Company Details

SectorHealthcare
IndustryMedical Distribution
CEOMr. Nanthiya Darakananda
Employees0
HeadquartersNo. 634/4 Soi Ramkhamhaeng 39, Bangkok, Thailand, 10310, Thailand
Websitehttps://www.winnergymedical.co.th

Leadership

Mr. Nanthiya DarakanandaCEO & Director · b. 1969
Ms. Ampaporn LamlertsaringkarnChief Financial Officer
Ms. Yodjuta kunjara Na AyudhyaChief Operating Officer
Ms. Mathurada MuanjumponHead of Accounting
Ms. Wanwisa SoisawatCompany Secretary & Head of Investor Relations
Mr. Olarn JarungthamchoteHead of the Compliance Unit
Ms. Chawanpat HomhwantipHead of Internal Audit
Ms. Pavarisa DamrongsuntisukCompany Secretary
Mr. Kamol SakulworapatsiriVice President of Finance Department · b. 1985

Financials

Income Statement

Currency: THB	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	382.68M	514.16M	492.38M	530.54M	538.70M	703.41M	639.18M	654.36M	647.04M
Growth (%)	-	+34.36%	-4.24%	+7.75%	+1.54%	+30.58%	-9.13%	+2.37%	-1.12%
Cost of Revenue	337.57M	281.65M	255.66M	282.33M	295.37M	441.55M	377.73M	386.08M	370.72M
Gross Profit	45.12M	232.51M	236.72M	248.21M	243.33M	261.87M	261.45M	268.27M	276.32M
Gross Margin	11.79%	45.22%	48.08%	46.79%	45.17%	37.23%	40.90%	41.00%	42.70%
Operating Expense	36.35M	164.25M	174.20M	178.22M	185.20M	201.62M	227.36M	243.80M	267.92M
Operating Income	8.77M	68.27M	62.52M	69.99M	58.12M	60.24M	34.09M	24.47M	8.40M
Operating Margin	2.29%	13.28%	12.70%	13.19%	10.79%	8.56%	5.33%	3.74%	1.30%
EBITDA	8.77M	89.38M	80.93M	93.16M	110.74M	117.19M	89.20M	96.20M	61.01M
EBITDA Margin	2.29%	17.38%	16.44%	17.56%	20.56%	16.66%	13.95%	14.70%	9.43%
Net Income	2.33M	-6.40M	45.27M	51.59M	65.21M	60.67M	30.64M	29.26M	15.17M
Net Income Margin	0.61%	-1.25%	9.19%	9.72%	12.10%	8.63%	4.79%	4.47%	2.34%
R&D	-	-	-	-	-	29.83K	-	-	-
R&D as % of Total Revenue	-	-	-	-	-	0.00%	-	-	-
Interest Expense	4.08M	12.72M	11.02M	8.05M	4.94M	6.87M	9.07M	12.17M	15.91M
Interest Expense % of Total Revenue	1.07%	2.47%	2.24%	1.52%	0.92%	0.98%	1.42%	1.86%	2.46%

Balance Sheet

Currency: THB	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	153.44M	102.97M	351.72M	331.60M	492.10M	755.46M	848.24M	977.88M	1.11B	1.14B
Total Liabilities	140.94M	98.14M	355.15M	241.04M	303.31M	183.47M	253.32M	373.86M	473.69M	504.92M
Total Equity	12.50M	4.83M	63.03M	90.56M	188.79M	571.99M	594.92M	604.02M	632.14M	635.32M
Cash	12.83M	8.22M	18.07M	7.32M	8.29M	126.41M	71.61M	34.73M	22.92M	19.37M
Total Debt	50.14M	70.00M	243.71M	104.63M	215.03M	63.46M	171.16M	256.13M	307.45M	362.72M
Net Debt	37.30M	61.78M	225.63M	97.31M	206.73M	-62.95M	99.56M	221.40M	284.54M	343.36M

Cash Flow

Currency: THB	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	78.01M	63.87M	78.01M	8.14M	90.78M	-74.51M	37.48M	111.13M	-24.90M
Investing Cash Flow	-20.24M	-14.42M	-20.24M	-97.24M	-136.49M	-49.74M	-89.70M	-181.63M	-23.57M
Financing Cash Flow	-105.32M	31.08M	-105.32M	90.07M	163.83M	69.45M	15.34M	58.68M	44.92M
Capital Expenditure	7.89M	14.42M	20.28M	52.13M	134.02M	66.03M	92.64M	194.89M	33.24M
Free Cash Flow	70.12M	49.45M	57.73M	-43.99M	-43.24M	-140.54M	-61.02M	-83.76M	-58.14M
Dividends Paid	8.24M	3.00M	8.24M	45.00M	41.69M	26.00M	22.76M	11.80M	9.90M
FCF to OCF	89.88%	77.42%	74.00%	-540.11%	-47.64%	188.61%	-162.80%	-75.37%	233.49%
Dividend Paid to FCF	11.75%	6.07%	14.28%	-102.30%	-96.41%	-18.50%	-37.30%	-14.09%	-17.03%

Earnings

Report Date	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.01	0.07	0.06	0.03	0.04	0.03	0.05	0.02	0.01	0.02	0.03	0.01	0.01	0.03	0.03	0.02	0.00	0.00	0.01	0.01
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap512.00M

Enterprise Value878.96M

Trailing P/E32.00

Forward P/E0.00

Price / Sales0.73

Price / Book0.79

EPS0.04

Book Value1.60

Revenue (TTM)699.71M

Gross Profit (TTM)299.32M

EBITDA50.99M

Profit Margin2.40%

Operating Margin7.88%

Return on Equity2.64%

Return on Assets0.56%

Shares Outstanding400.00M

Shares Float119.33M

Beta0.23

Dividend Yield1.00%

Dividend Rate0.01

Payout Ratio48.26%

Dividends

20261×

0.01Mar 16, 2026

20251×

0.02Mar 12, 2025

20241×

0.03Mar 12, 2024

20231×

0.06Mar 20, 2023

20221×

0.07Mar 17, 2022